Consulting AgreementConsulting Agreement • January 3rd, 2022 • Pluristem Therapeutics Inc • Biological products, (no disgnostic substances)
This Consulting Agreement (the “Agreement”) is entered into as of January 1st 2022 (the “Effective Date”) by and between Pluristem Ltd., with its principal place of business at MATAM Park, Building 5, Haifa 31905 Israel (“Company”), and Mr. Zalman (Zami) Aberman, Israeli ID# 26014043 from Tel Mond, Israel (“Consultant”).
